Non traditional risk factors of carotid atherosclerosis in rheumatoid arthritis

Egyptian Rheumatologist

Volumn 33, Issue 3, 2011, Pages 113-119

  Kassem, Elham ^a   Ghonimy, Raghda ^a   Adel, Mona ^a   El Sharnoby, Gehan ^a  

^a TANTA UNIVERSITY   (Egypt)

Author keywords

Carotid atherosclerosis; Non traditional risk factors; Rheumatoid arthritis

Indexed keywords

ALPHA TOCOPHEROL; C REACTIVE PROTEIN; INTERLEUKIN 6; PREDNISONE; RETINOL; RHEUMATOID FACTOR;

ADULT; ANAMNESIS; ARTERY DILATATION; ARTERY INTIMA PROLIFERATION; ARTICLE; BONE EROSION; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CAROTID ARTERY FLOW; CAROTID ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DOPPLER ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INFLAMMATION; LABORATORY TEST; MALE; MODIFIED LARSEN SCORE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; TREATMENT DURATION;

EID: 84880395806     PISSN: 11101164     EISSN: 20902433     Source Type: Journal    
DOI: 10.1016/j.ejr.2011.03.005     Document Type: Article

References (53)

1. Dessein P.H., Joffe B.I., Singh S. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 2005, 7(3):634-643.
2. Kaplan M.J. Cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol 2006, 18(3):289-297.
3. Pearson T.A., Mensah G.A., Alexander R.W. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107:499-511.
4. Goodson N.J., Symmons D.P., Scott D.J., et al. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten year follow up study of a primary care-based inception cohort. Arthritis Rheum 2005, 52:2293-2299.
5. Maradit-Kremers H., Nicola P.J., Crowson C.S., et al. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005, 52:722-732.
6. Steinberg D. Low density lipoprotein oxidation and its pathophysiological significance. J Biol Chem 1997, 272:20963-20966.
7. Pryor W.A. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radical Biol Med 2000, 28:141-164.
8. Bonetti P.O., Lerman L.O., Lerman A., et al. Endothelial dysfunction. A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003, 23:168-175.
9. Asselbergs F.W., van der Harst P., Jessurun G.A., et al. Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins. Vascul Pharmacol 2005, 42(3):125-140.
10. Meigs J.B., Hu F.B., Rifai N., Manson J.E. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004, 291:1978-1986.
11. Hwang S.-J., Ballantyne C.M., Sharrett A.R., et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. Circulation 1997, 96:4219-4225.
12. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the assessment of endothelial-flow-mediated vasodilatation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Carodiol 2002, 39(2):257-265.
13. Kumeda Y., Inaba M., Goto H., et al. Increase thickness of the arterial intema-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 2002, 46:1489-1497.
14. Javier Martin J., Gonzalez-Gay M.A. Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum 2009, 38(5):366-371.
15. Arnett F.C., Edworthy S.M., Bloch D.A. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
16. Mallya R.K., Mace B.E.W. The assessment of disease activity in rheumatoid arthritis using the multivariate analysis. Rheumatol Rehabil 1981, 20:14-20.
17. Fries J.F., Spitz P.O., Kraines R.G., et al. Measurement of patient outcome in arthritis. Arthritis Rheum 1980, 23:137-145.
18. Larsen A. How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long term studies?. J Rheumatol 1995, 22:1974-1975.
19. Dandilla K.L., McDuffie F.C. Rheumatoid factor determination. Arthritis Rheum 1962, 44:1736-1743.
20. Jong S.K., Yang H.K., Jin S.R. Serial measurement of Interleukin-6, transforming growth factor-beta, and S-100 protein in acute ischemic stroke patients. Stroke 1996, 27:1553-1557.
21. Catignani G.L., Bieri J.G. Simultaneous determination of retinol and -tocopherol in serum or plasma by liquid chromatography. Clin Chem 1983, 29:708-712.
22. Pauletto P., Palatini P., Da Ros S., Pagliara V., Santipolo N., Baccillieri S., Casiglia E., Mormino P., Pessina A.C. Factors underlying the increase in carotid intima-media thickness in borderline hypertensives. Arterioscler Thromb Vasc Biol 1999, 19(5):1231-1237.
23. Howard G., Sharrett A.R., Heiss G., et al. Carotid artery intema-media thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke 1993, 24:1297-1304.
24. World Health Organization Study Group on Diabetes Mellitus Report of a WHO Study Group. Geneva, World Health Organization; 1985.
25. Dessein P.H., Norton G.R., Woodiwiss A.J., et al. Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis patients. J Rheumatol 2007, 34:943-951.
26. Roman M.J., Davis A., Paget S.A., et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 2006, 144(4):249-256.
27. Del Rincon I., Williams K., Stern M.P., et al. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 2003, 48:1833-1840.
28. Salmon J.E., Roman M.J. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 2008, 121(10). Suppl. 1: S3-S8.
29. Szentpétery A., Besenyei T., Sziies G., et al. Accelerated atherosclerosis in rheumatoid arthritis. Ann N Y Acad Sci 2007, 1108:349-358.
30. Gerli R., Schillaci G., Giordano A., Bocci E.B., BiolSc O.B., Gaetano Vaudo G., Marchesi S., Pirro M., Ragni F., Shoenfeld Y., Mannarino F.E. CD4+CD28-T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis. Circulation 2004, 109:2744-2748.
31. Cox I.D., Claqu J.R., Bagger J.P., et al. Endothelial dysfunction, subangiographic atheroma and unstable symptoms in patients with chest pain and normal coronary arteriograms. Clin Cardiol 2000, 23:652-654.
32. Vita J.A., Keaney J.F. Endothelial function: a barometer for cardiovascular risk?. Circulation 2002, 106:640-642.
33. Ozbalkan Z., Cumali Efe C., Cesur M., Ertek S., Nasiroglu N., Berneis K., Rizzo M. An update on the relationships between rheumatoid arthritis and atherosclerosis. Atherosclerosis 2010, (Review) doi:10.1016/j.atherosclerosis.2010.03.035.
34. Wallberg-Jonsson S., Cvetkovic J.T., Sundqvist K.G., et al. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. J Rheumatol 2002, 29:875-882.
35. Katritsis D., Korovesis S., Giazitzoglou E., et al. Association of C-reactive protein with angiographic characteristics of coronary lesions. Clin Chem 2001, 47:882-886.
36. Ridker P.M. High-sensitivity C-reactive protein: potential adjunct for globar risk assessment in the primary prevention of cardiovascular disease. Circulation 2001, 103:1813.
37. Wallberg-Jonsson S., Johnsson H., Ohman M.L., Rantapaa-Dahlqvist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol 1999, 26:2562-2571.
38. Sattar N., McCarey D.W., Capell H., McInnes I.B. Explaining how " high grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003, 108:2957-2963.
39. Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Arthritis Rheum 2008, 21(10):S21-S31.
40. Rattazzi M., Pauto M., Faggin E., et al. C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders?. J Hypertens 2003, 21:1787-1803.
41. Karatas F., Ozates I., Canatan H., Halifeoglu I., Karatepe M., Colak R. Antioxidant status and lipid peroxidation in patients with rheumatoid arthritis. Indian J Med Res 2003, 118:178-181.
42. Paredes S., Girona J., Hurt-Camejo E., Vallve J.C. Antioxidant vitamins and lipid peroxidation in rheumatoid arthritis patients: association with inflammatory markers. J Rheumatol 2002, 29:2271-2277.
43. Uyma O., Yoshimoto Y., Yamamoto Y., Kawal A. Bone changes and carotid atherosclerosis in postmenopausal women. Stroke 1997, 28:1730-1732.
44. Barengolts E.I., Berman M., Kukreja S.C., et al. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 1998, 62:209-213.
45. Kelly C., Hamilton J. What kills patients with rheumatoid arthritis?. Rheumatology 2007, 46(2):183-184.
46. Turesson C., McClelland R.L., Christianson T.J.H., et al. Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 2007, 66:70-75.
47. Newkirk M.M. Rheumatoid factors: what do they tell us?. J Rheumatol 2002, 29:2034-2040.
48. Takemura S., Klimiuk P.A., Braun A., et al. T cell activation in rheumatoid csynovium is B cell dependent. J Immunol 2001, 167:7410-7418.
49. Aubry M.C., Riehl D.L., Edwards W.D., et al. B-lymphocyted in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: preliminary observations. Cardiovasc Pathol 2004, 13:233-236.
50. Googson N.J., Farragher M. Rheumatoid factor, smoking, and disease severity: associations with mortality in rheumatoid arthritis. J Rheumatol 2008, 35(6):945.
51. Manzi S., Selzer F., Sutton-Tyrrel K., et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erthymatosus. Arthritis Rheum 1999, 42:51-60.
52. Svenungsson E., Jensen-urstand K., Heimburger M., et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001, 104:1887-1893.
53. Hafstrom I., Rohani M., Deneberg S., et al. Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis - a randomized study. J Rheumatol 2007, 34(9):1810-1822.